28
Treatment
Medications for treatment of medication-induced
parkinsonism
a
Genric name
Trade name
Amantadine
Symmetrel
Benztropine mesylate
Cogentin
Renal impairment Elimination half-life
increases with renal
impairment
No dose adjustments
noted in labeling
Comments Negligible removal by
dialysis; do not crush or
divide extended release
products
Onset of action with
IV dose is comparable
to IM
a
This table includes information compiled from multiple sources. Detailed information on such
issues as dose regimen, dose adjustments, medication administration procedures, handling
precautions, and storage can be found in product labeling. It is recommended that readers
consult product labeling information for authoritative information on these medications.
(cont'd)
